SL Science Holding Ltd (SLBT) stock
SLBTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 18, 2026
$0.55−0.03 (-5.37%)
Close on Nov 20, 2026Market cap $308.42MP/E –Yield –
SL Science gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for SL Science
SL Science has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?